Clinical Trials on Gastro-enteropancreatic Neuroendocrine Tumor in United States
Total 2496 results
-
DermTechCompleted
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Northern California Melanoma CenterBayer; Melanoma Research InstituteCompleted
-
Titan PharmaceuticalsTerminated
-
SCRI Development Innovations, LLCGlaxoSmithKline; CelgeneWithdrawn
-
AdaptimmuneTerminated
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Survivors | Psychological FactorsUnited States
-
Aivita Biomedical, Inc.Recruiting
-
Novartis PharmaceuticalsTerminated
-
University of UtahCompletedMelanoma (Skin)United States
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Mt. Sinai Medical Center, MiamiNorthern California Melanoma CenterCompleted
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
Immunocore LtdTerminated
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
Ohio State University Comprehensive Cancer CenterCompletedSkin Cancer | Gastrointestinal Cancer | Neuroendocrine CarcinomaUnited States
-
Yale UniversityCompleted
-
Bristol-Myers SquibbCompleted
-
Douglas TylerVarian, a Siemens Healthineers CompanyCompleted
-
Diwakar DavarCompletedMelanomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbTerminatedMelanomaUnited States
-
Lisa H. Butterfield, Ph.D.National Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Baylor Research InstituteTerminatedMalignant Melanoma Stage IVUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingLung Non-Small Cell Squamous Carcinoma | Stage IIA Lung Cancer AJCC v8 | Neuroendocrine Carcinoma | Lung Atypical Carcinoid Tumor | Minimally Invasive Lung Adenocarcinoma | Lung Neuroendocrine Neoplasm | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterXcovery Holding Company, LLCActive, not recruiting
-
University of UtahCompletedMelanoma (Skin)United States
-
SciBase ABCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedMelanoma (Skin)United States
-
Northwell HealthCohen Children's Medical CenterAvailableNeuroblastoma | PheochromocytomaUnited States
-
Georgetown UniversityExelixis; Hackensack Meridian Health; MedStar Franklin Square Medical CenterSuspendedMelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
Duke UniversityCompletedHigh Risk MelanomaUnited States
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Islet Cell CarcinomaUnited States
-
Case Comprehensive Cancer CenterCompletedMetastatic or Unresectable MelanomaUnited States
-
Radio Isotope Therapy of AmericaRadiomedix, Inc.; Excel Diagnostic Imaging Clinics; CHI St. Luke's Health, TexasCompletedNeuroendocrine TumorsUnited States
-
Dana-Farber Cancer InstituteNovartisActive, not recruiting
-
M.D. Anderson Cancer CenterCelgeneCompletedMelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Skin MelanomaUnited States
-
Inova Health Care ServicesGenentech, Inc.Withdrawn
-
University of PittsburghBristol-Myers SquibbWithdrawnMelanomaUnited States
-
Ahmad TarhiniPfizerCompleted
-
Craig L Slingluff, JrTerminated